Inova Health Care Services
90
23
26
34
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
27.8%
25 terminated/withdrawn out of 90 trials
57.6%
-28.9% vs industry average
11%
10 trials in Phase 3/4
76%
26 of 34 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (90)
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
Role: lead
Hemoglobin Testing in Pregnant Patients
Role: lead
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Role: lead
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Role: lead
Volume Reduction for Open Fracture Irrigation
Role: lead
Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery
Role: lead
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF
Role: lead
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Role: lead
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
Role: lead
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
Role: lead
Inova Cardiogenic Shock Registry (INOVA SHOCK)
Role: lead
Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery
Role: lead
Activity Coaching During Pelvic Radiation Therapy
Role: lead
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Role: lead
Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer
Role: lead
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
Role: lead
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
Role: lead
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
Role: lead
Assessing Physical Function in Sickle Cell Patients Taking Voxelotor
Role: lead
Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults
Role: lead